RECURRENT CERVICAL CARCINOMA
Clinical trials for RECURRENT CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for advanced cervical cancer
Disease control OngoingThis study tested a drug called nivolumab in 26 people with cervical cancer that had come back or spread. Nivolumab is an immunotherapy that helps the immune system attack cancer cells. The goal was to see if it could shrink tumors and how safe it was. Results showed some tumor s…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:38 UTC
-
New drug combo shows promise against tough cervical cancer
Disease control OngoingThis study tests whether combining two drugs, dostarlimab and cobolimab, can shrink tumors or slow the disease in people with advanced or recurrent cervical cancer. About 66 participants with measurable tumors will receive the combination. The main goal is to see how many patient…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Blood test may tame Chemo's nerve pain
Knowledge-focused TerminatedThis study looks at whether regularly measuring the amount of paclitaxel (a chemotherapy drug) in the blood can help doctors give the right dose to kill cancer while limiting nerve damage. About 22 adults with various solid tumors (like lung, breast, or ovarian cancer) will have …
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes in a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers (solid tumors, lymphoma, or myeloma) had their tumors genetically screened. Those with specific genetic c…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Can a simple blood test predict cervical Cancer's next move?
Knowledge-focused OngoingThis study looks at whether a blood test can find tiny bits of HPV DNA from cervical cancer tumors. Researchers will test blood samples from 18 people with cervical cancer before, during, and after treatment. The goal is to see if changes in this DNA can help predict how well tre…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC